Ligand validation:6XXI

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 6XXI designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6XXI_NAD_B_1510	77%	50%	0.133	0.974	1.03	0.9	2	2	0	0	100%	0.97
6XXI_NAD_A_1105	70%	29%	0.161	0.981	1.19	1.78	4	12	1	0	100%	0.97
8A0F_NAD_B_403	90%	56%	0.083	0.965	0.66	1.01	-	2	1	0	100%	1
6P4V_NAD_A_501	85%	55%	0.11	0.976	0.73	0.98	1	3	1	0	100%	1
8A0G_NAD_A_403	85%	53%	0.112	0.978	0.81	1	-	4	0	0	100%	1
1DHS_NAD_A_700	84%	30%	0.108	0.971	1.47	1.47	7	7	2	0	100%	1
6XXJ_NAD_A_402	81%	37%	0.116	0.968	1.14	1.43	4	6	1	0	100%	0.94
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.